BRAFV600E Status in Solitary and Multiple Papillary Thyroid Carcinoma and in Their Lymph-Node and Distant Metastases: An Immunochemical and Genotypic Retrospective Study of 363 Consecutive Patients

被引：0
|
作者：
Eymerit-Morin, Caroline
Buffet, Camille
Cancel-Tassin, Geraldine
Roger, Mouawad
Gaffory, Cecile
Lesot, Annette
Le Naour, Gilles
Herve, Genevieve
Wassermann, Johanna
Khayat, David
Tresallet, Christophe
Leenhardt, Laurence
Menegaux, Fabrice
Rousselet, Marie-Christine
Capron, Frederique
Tissier, Frederique
机构：
[1] CHU Angers, Angers, France
[2] Univ Paris 04, UPMC, HUPS, AP HP, Paris, France
[3] HUPS, Paris, France
[4] UPMC, HUPS, Lab AVEC, Paris, France
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
524
引用
收藏
页码：134A / 134A
页数：1
相关论文
共 50 条
  • [1] BRAFV600E Status in Solitary and Multiple Papillary Thyroid Carcinoma and in Their Lymph-Node and Distant Metastases: An Immunochemical and Genotypic Retrospective Study of 363 Consecutive Patients
    Eymerit-Morin, Caroline
    Buffet, Camille
    Cancel-Tassin, Geraldine
    Roger, Mouawad
    Gaffory, Cecile
    Lesot, Annette
    Le Naour, Gilles
    Herve, Genevieve
    Wassermann, Johanna
    Khayat, David
    Tresallet, Christophe
    Leenhardt, Laurence
    Menegaux, Fabrice
    Rousselet, Marie-Christine
    Capron, Frederique
    Tissier, Frederique
    LABORATORY INVESTIGATION, 2015, 95 : 134A - 134A
  • [2] Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma
    Choi, Yong Won
    Kim, Young Hwa
    Lee, Jeonghun
    Soh, Euy Young
    Park, Tae Jun
    Kim, Jang-Hee
    HUMAN PATHOLOGY, 2015, 46 (10) : 1557 - 1565
  • [3] Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma
    Park, Tae Jun
    Choi, Yong Won
    Kim, Jang-Hee
    Lim, In Kyoung
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients
    Zhao, Hao
    Liu, Chun-hao
    Lu, Ying
    Liu, Shu-Zhou
    Yeerkenbieke, Palashate
    Cao, Yue
    Xia, Yu
    Gao, Lu-Ying
    Liu, Yue-Wu
    Liu, Zi-Wen
    Chen, Shu-Guang
    Liang, Zhi-Yong
    Li, Xiao-Yi
    ORAL ONCOLOGY, 2024, 152
  • [5] Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features
    Li, Gui-you
    Tani, Hai-long
    Chen, Pei
    Hu, Hui-Yu
    Liui, Mian
    Ou-yang, Deng-jie
    Khushbui, Rooh-afza
    Pun, Deepak
    Li, Jin-dong
    Zhang, Zhi-peng
    Yang, Qiong
    Huang, Peng
    Chang, Shi
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3371 - 3378
  • [6] Retrospective study of BRAFV600E mutation and CT features of papillary thyroid carcinoma
    Hong, Xiaoquan
    Li, Juxiang
    Duan, Shaoyin
    You, Youkuang
    PEERJ, 2024, 12
  • [7] The status of BRAFV600E mutation among Egyptian patients with papillary thyroid carcinoma
    El Tawil A.
    Mehaney D.
    Anis S.
    Salama A.
    Khattab H.
    El-Refaei S.
    Comparative Clinical Pathology, 2015, 24 (4) : 715 - 720
  • [8] The effect of BRAFV600E mutation on lymph node involvement in papillary thyroid cancer
    Sahin, Samet
    Daglar, Gul
    Menekse, Ebru
    Cavdarli, Busranur
    Baglan, Tolga
    TURKISH JOURNAL OF SURGERY, 2020, 36 (03) : 249 - 255
  • [9] Detection of Circulating BRAFV600E in Patients with Papillary Thyroid Carcinoma
    Lubitz, Carrie C.
    Parangi, Sareh
    Holm, Tammy M.
    Bernasconi, M. Jordana
    Schalck, Aislyn P.
    Suh, Hyunsuk
    Economopoulos, Konstantinos P.
    Gunda, Viswanath
    Donovan, Samuel. E.
    Sadow, Peter M.
    Wirth, Lori J.
    Sullivan, Ryan J.
    Panka, David J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (01): : 100 - 108
  • [10] Comment on BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients
    Sekar, Durairaj
    ORAL ONCOLOGY, 2024, 152
12345